Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

被引:32
|
作者
Vosnakis, Christos [1 ]
Georgopoulos, Neoklis A. [2 ]
Rousso, David [1 ]
Mavromatidis, Georgios [1 ]
Katsikis, Ilias [3 ]
Roupas, Nikolaos D. [2 ]
Mamali, Irene [2 ]
Panidis, Dimitrios [3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 3, GR-54006 Thessaloniki, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, Patras 26500, Greece
[3] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, GR-54006 Thessaloniki, Greece
关键词
Anti-Mullerian Hormone; LH; insulin resistance; Orlistat; PCOS; INHIBITING SUBSTANCE LEVELS; LUTEINIZING-HORMONE; INSULIN-RESISTANCE; MOUSE OVARY; LEAN WOMEN; OBESITY; GROWTH; ASSOCIATION; GHRELIN; FSH;
D O I
10.3109/09513590.2012.736557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigates the combined effect of diet, physical exercise and Orlistat for 24 weeks, on serum Anti-Mullerian Hormone (AMH) levels in overweight and obese women with polycystic ovary syndrome (PCOS) and in overweight and obese controls. Sixty-one (61) selected women with PCOS and 20 overweight and obese controls followed an energy-restricted diet, physical exercise plus Orlistat administration (120 mg, 3 times per day) for 24 weeks. At baseline, week 12 and week 24, serum levels of AMH, FSH, LH, PRL, androgens, sex hormone-binding globulin (SHBG), glucose, and insulin were measured and Free Androgen Index (FAI) and Insulin Resistance (IR) indices were calculated. In PCOS women, serum AMH levels increased after 12 and 24 weeks of treatment. After 12 weeks LH and SHBG were increased, while Testosterone decreased. After 12 and 24 weeks, FAI was decreased and all indices of IR were significantly improved. We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [1] Sibutramine administration decreases serum anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome
    Vosnakis, Christos
    Georgopoulos, Neoklis A.
    Armeni, Anastasia K.
    Papadakis, Efstathios
    Roupas, Nikolaos D.
    Katsikis, Ilias
    Panidis, Dimitrios
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (02) : 185 - 189
  • [2] Anti-Mullerian Hormone (AMH) Levels in Women with and without Polycystic Ovary Syndrome (PCOS)
    Sadiq, Iftikhar
    Qamar, Misbahul
    Janjua, Qasim Mehmood
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (02): : 564 - 566
  • [3] Serum Anti-Mullerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses
    Detti, Laura
    Christiansen, Mary E.
    Francillon, Ludwig
    Ikuwezunma, Gini
    Diamond, Michael P.
    Mari, Giancarlo
    Tobiasz, Ana M.
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2019, 65 (02) : 147 - 154
  • [4] Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
    Falbo, Angela
    Rocca, Morena
    Russo, Tiziana
    D'Ettore, Antonietta
    Tolino, Achille
    Zullo, Fulvio
    Orio, Francesco
    Palomba, Stefano
    JOURNAL OF OVARIAN RESEARCH, 2010, 3
  • [5] Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome
    Wong, Ho Yan Queenie
    Li, Hang Wun Raymond
    Lam, Karen Siu Ling
    Tam, Sidney
    Shek, Chi Chung
    Lee, Chi Yan Vivian
    Yeung, William Shu Biu
    Ho, Pak Chung
    Ng, Ernest Hung Yu
    CLINICAL ENDOCRINOLOGY, 2018, 89 (05) : 634 - 641
  • [6] The role of serum anti-Mullerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome
    Casadei, Luisa
    Madrigale, Alessandra
    Puca, Francesco
    Manicuti, Claudia
    Emidi, Emanuela
    Piccione, Emilio
    Dewailly, Didier
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (06) : 545 - 550
  • [7] Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women
    Stracquadanio, M.
    Ciotta, L.
    Palumbo, M. A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (03) : 223 - 228
  • [8] Comparison of Anti-mullerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome
    Ozay, Ali Cenk
    Ozay, Ozlen Emekci
    Gulekli, Bulent
    GINEKOLOGIA POLSKA, 2020, 91 (11) : 661 - 667
  • [9] Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
    Sahmay, Sezai
    Atakul, Nil
    Oncul, Mahmut
    Tuten, Abdullah
    Aydogan, Begum
    Seyisoglu, Hakan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (01) : 157 - 161
  • [10] Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS)
    Park, Hyun T.
    Cho, Geum J.
    Ahn, Ki H.
    Shin, Jung H.
    Kim, Young T.
    Hur, Jun Y.
    Kim, Sun H.
    Lee, Kyu W.
    Kim, Tak
    CLINICAL ENDOCRINOLOGY, 2010, 72 (01) : 26 - 31